Quest Diagnostics' Q2 Revenues Up 1 Percent; Updates 2015 Guidance | GenomeWeb

NEW YORK (GenomeWeb) -- Quest Diagnostics today reported that its second quarter revenues were up 1 percent year over year, meeting analysts' consensus estimate.

Quest's revenues for the three months ended June 30 were $1.93 billion compared to $1.90 billion for the second quarter in 2014. The top-line figure matched Wall Street's expectation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.